Discounted Cash Flow Rating

Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Strong Buy

Exponential Moving Average

Strong Buy

Relative Strength Index

Neutral

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Forte Biosciences, Inc. Common Stock (FBRX)

Pharmaceutical Preparations

https://www.fortebiorx.com

Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease ("GvHD"), vitiligo and alopecia areata ("AA"). The company is developing a live biotherapeutic, FB-401, for the treatment of inflammatory skin diseases. FB-401 has completed Phase 1/2a testing in adult and pediatric patients with atopic dermatitis. It plans to advance FB-401 into a randomized Phase 2 clinical trial.

3060 PEGASUS PARK DRIVE, BUILDING 6
DALLAS, TX

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

06/16/2020

Market Cap

10,794,233

Shares Outstanding

36,340,000

Weighted SO

36,335,105

Total Employees

N/A

Upcoming Earnings

08/12/2024

Similar Tickers

INDP --.--%

RZLT --.--%

TPST --.--%

CMRA --.--%

ABVC --.--%

KTTA --.--%

BTTX --.--%

ZIVO --.--%

THRX --.--%

Beta

1.4800

Last Div

0.0000

Range

0.28-0.915

Chg

-0.0113

Avg Vol

46337

Mkt Cap

10794233

Exch

NASDAQ

Country

US

Phone

310 618 6994

DCF Diff

-0.0689

DCF

0.3789

Div Yield

0.0000

P/S

1799.0388

EV Multiple

-0.0328

P/FV

0.8043

Div Yield %

0.0000

P/E

-0.3815

PEG

0.0153

Payout

0.0000

Current Ratio

2.8201

Quick Ratio

2.8201

Cash Ratio

1.0503

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

68763.3929

CCC

-68763.3929

Gross Margin

-3.6667

Op Margin

-6203.1667

Pretax Margin

-5959.6667

Net Margin

-5959.6667

Eff Tax Rate

-0.0021

ROA

-1.3712

ROE

-1.1785

ROCE

-2.1944

NI/EBT

1.0000

EBT/EBIT

0.9607

EBIT/Rev

-6203.1667

Debt Ratio

0.0000

D/E

0.0000

LT Debt/Cap

0.0000

Total Debt/Cap

0.0000

Int Coverage

-364.8922

CF/Debt

0.0000

Equity Multi

1.5375

Rec Turnover

0.0000

Pay Turnover

0.0053

Inv Turnover

0.0000

FA Turnover

0.0625

Asset Turnover

0.0002

OCF/Share

-0.6640

FCF/Share

-0.6660

Cash/Share

0.5311

OCF/Sales

-5105.0000

FCF/OCF

1.0031

CF Coverage

0.0000

ST Coverage

0.0000

CapEx Coverage

-325.8511

Div&CapEx Cov

-325.8511

P/BV

0.8043

P/B

0.8043

P/S

1799.0388

P/E

-0.3815

P/FCF

-0.3513

P/OCF

-0.4453

P/CF

-0.4453

PEG

0.0153

P/S

1799.0388

EV Multiple

-0.0328

P/FV

0.8043

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation